MO SB 1156
died on adjournmentSB 1156 - This act prohibits health benefit plans from imposing cost-sharing, as defined in the act, on an enrollee in excess of thirty dollars per thirty-day supply of a prescription insulin drug. This act also requires health benefit plan enrollees' cost-sharing for prescription insulin drugs to be calculated at the point of sale, and based on a price that is reduced by an amount equal to at least 100% of all rebates received, or to be received, in connection with the dispensing or administration of the drug. Nothing in the act shall prohibit copayments not based on the price of a drug, provided that the copayment does not exceed the reduced price of the drug. The act shall not require a health carrier or its agents to reveal information regarding the actual amount of rebates a carrier receives on a product, manufacturer, or pharmacy-specific basis. The act also provides confidentiality protections, as specified in the act, which the carriers shall follow as well as impose on any third party that performs health care or administrative services on behalf of the carrier and may receive or have access to rebate information. This act applies to health benefit plans delivered, issued, continued, or renewed in the state on or after January 1, 2027. This act is identical to HB 3117 (2026), SB 175 (2025), similar to provisions in HCS/HB 1195 (2025) and HB 186 (2025), identical to HB 2262 (2024), substantially similar to SB 1182 (2024), identical to SB 283 (2023), similar to SB 815 (2022), and contains provisions similar to SB 814 (2022). TAYLOR MIDDLETON
Missouri · 2026 Regular Session · upper
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did MO SB 1156 pass?
No. MO SB 1156 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-01-15): Second Read and Referred S Insurance and Banking Committee
What is MO SB 1156 about?
MO SB 1156 is a bill in the 2026 Regular Session titled “SB 1156 - This act prohibits health benefit plans from imposing cost-sharing, as defined in the act, on an enrollee in excess of thirty dollars per thirty-day supply of a prescription insulin drug. This act also requires health benefit plan enrollees' cost-sharing for prescription insulin drugs to be calculated at the point of sale, and based on a price that is reduced by an amount equal to at least 100% of all rebates received, or to be received, in connection with the dispensing or administration of the drug. Nothing in the act shall prohibit copayments not based on the price of a drug, provided that the copayment does not exceed the reduced price of the drug. The act shall not require a health carrier or its agents to reveal information regarding the actual amount of rebates a carrier receives on a product, manufacturer, or pharmacy-specific basis. The act also provides confidentiality protections, as specified in the act, which the carriers shall follow as well as impose on any third party that performs health care or administrative services on behalf of the carrier and may receive or have access to rebate information. This act applies to health benefit plans delivered, issued, continued, or renewed in the state on or after January 1, 2027. This act is identical to HB 3117 (2026), SB 175 (2025), similar to provisions in HCS/HB 1195 (2025) and HB 186 (2025), identical to HB 2262 (2024), substantially similar to SB 1182 (2024), identical to SB 283 (2023), similar to SB 815 (2022), and contains provisions similar to SB 814 (2022). TAYLOR MIDDLETON”.
Who sponsors MO SB 1156?
Nurrenbern, Maggie is the primary sponsor of MO SB 1156.
Description
SB 1156 - This act prohibits health benefit plans from imposing cost-sharing, as defined in the act, on an enrollee in excess of thirty dollars per thirty-day supply of a prescription insulin drug. This act also requires health benefit plan enrollees' cost-sharing for prescription insulin drugs to be calculated at the point of sale, and based on a price that is reduced by an amount equal to at least 100% of all rebates received, or to be received, in connection with the dispensing or administration of the drug. Nothing in the act shall prohibit copayments not based on the price of a drug, provided that the copayment does not exceed the reduced price of the drug. The act shall not require a health carrier or its agents to reveal information regarding the actual amount of rebates a carrier receives on a product, manufacturer, or pharmacy-specific basis. The act also provides confidentiality protections, as specified in the act, which the carriers shall follow as well as impose on any third party that performs health care or administrative services on behalf of the carrier and may receive or have access to rebate information. This act applies to health benefit plans delivered, issued, continued, or renewed in the state on or after January 1, 2027. This act is identical to HB 3117 (2026), SB 175 (2025), similar to provisions in HCS/HB 1195 (2025) and HB 186 (2025), identical to HB 2262 (2024), substantially similar to SB 1182 (2024), identical to SB 283 (2023), similar to SB 815 (2022), and contains provisions similar to SB 814 (2022). TAYLOR MIDDLETON
- Introduced
- —
- Latest action
- 2026-01-15 — Second Read and Referred S Insurance and Banking Committee
- Bill type
- bill
- Last updated
- —
Sponsors
- Nurrenbern, Maggieprimary
Committees
Not provided by source.
Action timeline
Newest first
2026-01-15
Second Read and Referred S Insurance and Banking Committee
reading-2,referral-committee
2026-01-07
S First Read
reading-1
2025-12-01
Prefiled
Versions
- 3850S.01I - IntroducedCompare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:25:15.077812Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MO&identifier=SB 1156. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.